scholarly article | Q13442814 |
P356 | DOI | 10.1002/1097-0215(20001201)88:5<783::AID-IJC16>3.0.CO;2-M |
P698 | PubMed publication ID | 11072249 |
P50 | author | Alain Ravaud | Q56548743 |
P2093 | author name string | J L Pariente | |
R Gaston | |||
D Verdier | |||
M Delaunay | |||
V Coulon | |||
N Gualde | |||
V Scrivante | |||
P2860 | cites work | In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas | Q24652833 |
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells | Q34029001 | ||
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma | Q36080365 | ||
Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity | Q36366051 | ||
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro | Q37358326 | ||
Role of the CD28 receptor in T-cell activation | Q37881494 | ||
Molecular interactions in macrophage activation | Q38666516 | ||
Natural history of HLA expression during tumour development. | Q40797268 | ||
Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells | Q40885233 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Antigen presentation by MHC class I and II molecules | Q41228247 | ||
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours | Q41370602 | ||
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells | Q59067424 | ||
TNF in Pathophysiology: Biosynthetic Regulation | Q67677221 | ||
Both dendritic cells and monocytes induce autologous and allogeneic T cells receptive to interleukin 2 | Q68409721 | ||
Interleukin-10, interleukin-12, and tumor necrosis factor-alpha differentially influence the proliferation of human CD8+ and CD4+ T-cell clones | Q71065407 | ||
Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions | Q71119379 | ||
Analysis of dendritic-cell-induced primary T-cell responses between HLA genotypically identical individuals | Q71151080 | ||
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity | Q71563753 | ||
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3 | Q71628036 | ||
Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses | Q71714697 | ||
Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes | Q71740206 | ||
Effect of stem cell factor (c‐ kit ligand), granulocyte‐macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long‐term bone marrow cultures | Q72106047 | ||
Ia antigens are the stimulating determinants in the syngeneic mixed lymphocyte reaction | Q72669126 | ||
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts | Q73209043 | ||
Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow | Q73592993 | ||
Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer | Q73676304 | ||
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides | Q73899169 | ||
In vitro production of human antigen presenting cells issued from bone marrow of patients with cancer | Q73935713 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 783-790 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | International Journal of Cancer | Q332492 |
P1476 | title | In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates | |
P478 | volume | 88 |
Search more.